Crystal structure of butenafine hydrochloride, C23H28NCl
Journal Article
·
· Powder Diffraction
- Illinois Institute of Technology, Chicago, IL (United States); North Central College, Naperville, IL (United States)
- ICDD, Newtown Square, PA (United States)
The crystal structure of butenafine hydrochloride has been solved and refined using synchrotron X-ray powder diffraction data, and optimized using density functional theory techniques. Butenafine hydrochloride crystallizes in space group P21 (#4) with a = 13.94807(5), b = 9.10722(2), c = 16.46676(6) Å, β = 93.9663(5)°, V = 2086.733(8) Å3, and Z = 4. Butenafine hydrochloride occurs as a racemic co-crystal of R and S enantiomers of the cation. The crystal structure is characterized by parallel stacks of aromatic rings along the b-axis. Each cation forms a strong discrete N–H∙∙∙Cl hydrogen bond. The chloride anions also act as acceptors in several C–H∙∙∙Cl hydrogen bonds from methylene, methyl, and aromatic groups. The powder pattern has been submitted to ICDD for inclusion in the Powder Diffraction File™ (PDF®).
- Research Organization:
- Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
- Sponsoring Organization:
- USDOE Office of Science (SC), Basic Energy Sciences (BES)
- Grant/Contract Number:
- AC02-06CH11357
- OSTI ID:
- 2423336
- Journal Information:
- Powder Diffraction, Journal Name: Powder Diffraction Journal Issue: 1 Vol. 38; ISSN 0885-7156
- Publisher:
- Cambridge University PressCopyright Statement
- Country of Publication:
- United States
- Language:
- English
Similar Records
Crystal structure of besifloxacin hydrochloride, C19H22ClFN3O3Cl
Crystal structure of ractopamine hydrochloride, C18H24NO3Cl
Crystal structure of alectinib hydrochloride Type I, C30H35N4O2Cl
Journal Article
·
Thu Jan 26 19:00:00 EST 2023
· Powder Diffraction
·
OSTI ID:2423335
Crystal structure of ractopamine hydrochloride, C18H24NO3Cl
Journal Article
·
Wed Feb 28 19:00:00 EST 2024
· Powder Diffraction
·
OSTI ID:2581380
Crystal structure of alectinib hydrochloride Type I, C30H35N4O2Cl
Journal Article
·
Sun May 19 20:00:00 EDT 2024
· Powder Diffraction
·
OSTI ID:2581385